Q61.1
Polycystic kidney, infantile type
Clinical Classification Guidelines
Inclusion Terms
- Polycystic kidney, autosomal recessive
Medical Intelligence & Overview
Polycystic kidney disease, infantile type, also known as autosomal recessive polycystic kidney disease (ARPKD), is a rare genetic disorder characterized by the development of numerous cysts in the kidneys of affected infants and young children. These cysts can lead to enlarged kidneys and impair normal kidney function, often presenting in early childhood. This condition is different from the more common adult form of polycystic kidney disease and requires careful medical management to address its unique challenges.
Causes & Symptoms
Clinical Causes: Inherited genetic mutation affecting the PKHD1 gene Autosomal recessive pattern of inheritance, meaning both parents carry the faulty gene Mutations disrupt normal development of the kidneys and bile ducts No known environmental or lifestyle factors directly cause this condition
Key Symptoms: Enlarged kidneys detectable via imaging studies High blood pressure, which can develop early Urinary tract infections Poor growth and failure to thrive in infants Hematuria (blood in the urine) Signs of kidney failure, such as swelling in the legs and high levels of waste in the blood In some cases, liver abnormalities including biliary duct dilation
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of imaging tests and genetic analysis. These include:
Treatment Protocols: While there is no cure for ARPKD, management focuses on alleviating symptoms and preventing complications. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is Q61.1 a billable ICD-10 code?
Yes, Q61.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q61.1?
Clinical documentation must specify the nature of Polycystic kidney, infantile type and any associated comorbidities for accurate reporting.
Cite this Clinical Reference